As a global specialty chemicals company, Altana develops innovative technologies, solutions, and products with a clear customer focus. The company aims to strengthen and expand this position in the long term. The topic of digital transformation plays a key role.
As it continues to leverage earnings from its top-selling mRNA-based Covid vaccine to deepen its existing knowhow, Mainz, Germany-based BioNtech has announced plans to acquire all of London-based artificial intelligence specialist InstaDeep.
French pharma Sanofi has entered a multi-year, multi-target research collaboration worth up to $1.2 billion with Hong Kong biotech Insilico Medicine.
Artificial intelligence (AI) has become one of the supporting pillars for digitalization in many areas of the business world. The pharmaceutical industry and its GxP-regulated areas also want to use AI in a beneficial way, but only a small fraction of companies follows a systematic approach for the digitalization of their operations and validation. However, the assurance of integrity and quality of outputs via computerized system validation is essential for applications in GxP environments.
Interview with Joachim Haupt and Florian Kaiser, PharmAI
French drugmaker Sanofi is taking an equity stake worth $180 million in and entering a new strategic collaboration with artificial intelligence (AI) and precision medicine specialist Owkin.
Andreas Helget, Managing Director of Yokogawa Germany, about the importance of digital transformation on the way to autonomous systems.
In January, Schrödinger, a provider of integrated software solutions, and the life sciences company Bayer announced a 5-year technology alliance to develop a comprehensive de novo design solution to accelerate the discovery of innovative, high-quality drugs.
Why BASF Venture Capital is investing in SmartAHC, a supplier of digitalization solutions for pig farming on the Chinese market.
Molecule.one leverages artificial intelligence (AI) to design novel chemical syntheses. As a response to the outbreak of the Covid-19 pandemic, the Polish start-up based in Warsaw has set out on the mission to accelerate the process of creating medicines.
